Survival analysis of palliative radiotherapy in patients with HER-2+ metastatic breast cancer

Survival analysis of palliative radiotherapy in patients with HER-2+ metastatic breast cancer

BackgroundWhether radiotherapy can improve the long-term survival of HER-2+ metastatic breast cancer remains unclear. We launched this study to explore the effect of HER-2+ metastatic breast cancer patients through anti-HER-2 targeted therapy + radiotherapy.Methods488 HER-2 + metastatic breast cance...

Full description

Bibliographic Details
Main Authors: Xueting Li, Xiaorong Zhong, Hongyu Xu, Jun Wang, Xianguo Liu, Yang Wang, Liang He, Jiayu Ma, Guanghua Li, Lei Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Endocrinology
Subjects:
radiotherapy
HER-2
breast cancer
overall survival
targeted therapy for metastatic breast cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1305429/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1305429/full

Similar Items